CureVac N.V. (CVAC)
NASDAQ: CVAC · Real-Time Price · USD
5.44
-0.02 (-0.37%)
At close: Aug 8, 2025, 4:00 PM
5.43
-0.01 (-0.18%)
After-hours: Aug 8, 2025, 6:29 PM EDT
CureVac Market Cap
CureVac has a market cap or net worth of $1.22 billion as of August 8, 2025. Its market cap has increased by 51.70% in one year.
Market Cap
1.22B
Enterprise Value
791.57M
1-Year Change
51.70%
Ranking
Category
Stock Price
$5.44
Market Cap Chart
Since the IPO on August 14, 2020, CureVac's market cap has decreased from $9.84B to $1.22B, a decrease of -87.55%. That is a compound annual growth rate of -34.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 1.22B | 60.14% |
| Dec 31, 2024 | 764.91M | -18.86% |
| Dec 29, 2023 | 942.72M | -17.82% |
| Dec 30, 2022 | 1.15B | -82.12% |
| Dec 31, 2021 | 6.42B | -55.14% |
| Dec 31, 2020 | 14.31B | 45.43% |
| Aug 14, 2020 | 9.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 575.32B |
| Johnson & Johnson | 413.10B |
| AbbVie | 351.30B |
| Abbott Laboratories | 229.85B |
| AstraZeneca | 227.78B |
| Novartis AG | 223.01B |
| UnitedHealth Group | 221.95B |
| Novo Nordisk | 213.92B |